SCHEMBL1328183

SCHEMBL1328183

CN(C)C(CCc1ccccc1)C1CCC(NC(=O)c2ccc(F)c(C(F)(F)F)c2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.58
TAS1R1 Q7RTX1 2/20 0.58
TAS1R2 Q8TE23 2/20 0.58
VNN1 O95497 1/20 0.42
MCHR1 Q99705 4/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA1A P35348 1/20 0.41
HRH1 P35367 1/20 0.41
HTR2B P41595 1/20 0.41
NPY5R Q15761 1/20 0.41
DRD4 P21917 5/20 0.40
UBE2M P61081 1/20 0.40
DCUN1D1 Q96GG9 1/20 0.40
DPP4 P27487 3/20 0.39
KCNH2 Q12809 3/20 0.39
DPP7 Q9UHL4 3/20 0.39
MAOB P27338 1/20 0.39
MAPK14 Q16539 1/20 0.39
DRD2 P14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1328539 0.85 MCHR1 (0.54) MCHR1ADRA2ADRD4DRD2SLC6A12
SCHEMBL1326600 0.82 CRHR1 (0.53) MCHR1ADRA2ADRD4KCNH2TMEM97
SCHEMBL1327976 0.81 ALDH1A1 (0.43) TAS1R3TAS1R1TAS1R2MCHR1ADRA2A
SCHEMBL2305482 0.81 CTDSP1 (0.53) MCHR1ADRA2AADRA1AHRH1HTR2B
SCHEMBL1327905 0.80 KMT2A (0.56) MCHR1ADRA2ADRD4MAPK14TMEM97
SCHEMBL1327203 0.75 TAS1R3 (0.59) TAS1R3TAS1R1TAS1R2MCHR1HTR1A
SCHEMBL493561 0.75 SMYD3 (0.48) SIGMAR1
SCHEMBL10226904 0.74 TAS1R3 (1.00) TAS1R3TAS1R1TAS1R2MCHR1MAPK14
SCHEMBL492989 0.74 RAB9A (0.43) DPP4DPP7
SCHEMBL492991 0.74 EPHX2 (0.43) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058475-B2 Substituted cyclohexylmethyl compounds GRUENENTHAL GMBH (DE) 2011-11-15 US claimed
EP-1989174-B1 SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES GRUENENTHAL GMBH (DE) 2011-08-03 EP claimed
US-20090286833-A1 Substituted Cyclohexylmethyl Compounds GRUENENTHAL GMBH (DE) 2009-11-19 US claimed
US-8058475-B2 Substituted cyclohexylmethyl compounds GRUENENTHAL GMBH (DE) 2011-11-15 US disclosed
EP-1989174-B1 SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES GRUENENTHAL GMBH (DE) 2011-08-03 EP disclosed
US-20090286833-A1 Substituted Cyclohexylmethyl Compounds GRUENENTHAL GMBH (DE) 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286833-A1 Substituted Cyclohexylmethyl Compounds CNR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, C1R TAS1R3 1404/4885TAS1R1 1147/4885TAS1R2 1238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.